Literature DB >> 26582528

[A quick and efficient method to generate hemophilia B mouse models by the CRISPR/Cas system].

Qi-han Wang1, Cong Huai1, Rui-lin Sun2, Hua Zhuang2, Hong-yan Chen1, Jian Fei2, Da-ru Lu1.   

Abstract

Hemophilia B, or the Christmas disease, is a common human disease caused by coagulation factor Ⅸ (FⅨ) deficiency. It is an X-linked recessive hereditary disease. Here we obtained FⅨ-knockout mouse strains with phenotype of hemophilia B with the CRISPR/Cas system efficiently. We chose the 8th exon as the target locus, and co-injected codon-optimized Cas9 mRNA with sgRNA of FⅨ into C57BL/6 mice zygotes. We obtained 60 mice in total and genotyped them by high resolution melting (HRM) and sequencing. The results showed the mutation rate was 85.0% in total, and 79.5% and 95.2% in males and females, respectively. No off-targets were detected in the similar locus by HRM. We future measured the FⅨ activity of each mice. The FⅨ: C of mutant mice were significantly below the normal level and reduced to 6.82% of wild-type mice. The activity assay demonstrated that all the mutant mice were lack of FⅨ. In summary, we have generated hemophilia B model mice with extreme efficiency, using the RNA-guided Cas9 nuclease gene editing system.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26582528     DOI: 10.16288/j.yczz.15-117

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  1 in total

1.  CRISPR/Cas9-mediated somatic and germline gene correction to restore hemostasis in hemophilia B mice.

Authors:  Cong Huai; Chenqiang Jia; Ruilin Sun; Peipei Xu; Taishan Min; Qihan Wang; Chengde Zheng; Hongyan Chen; Daru Lu
Journal:  Hum Genet       Date:  2017-05-15       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.